Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial
- PMID: 37963304
- DOI: 10.1200/JCO.23.00339
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial
Abstract
Olaparib improved PFS and OS across subgroups of BRCA1/2mut #prostatecancer patients in the PROFOUND phase III trial.
Trial registration: ClinicalTrials.gov NCT02987543.
Similar articles
-
Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?Pharmacogenomics. 2021 Aug;22(13):809-819. doi: 10.2217/pgs-2021-0061. Epub 2021 Sep 14. Pharmacogenomics. 2021. PMID: 34517749
-
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.Eur Urol. 2019 Oct;76(4):452-458. doi: 10.1016/j.eururo.2019.02.002. Epub 2019 Feb 21. Eur Urol. 2019. PMID: 30797618 Free PMC article.
-
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Eur Urol. 2021 Jun;79(6):710-712. doi: 10.1016/j.eururo.2021.02.041. Epub 2021 Mar 12. Eur Urol. 2021. PMID: 33722420
-
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities.Oncologist. 2016 Aug;21(8):940-5. doi: 10.1634/theoncologist.2016-0135. Epub 2016 Jun 17. Oncologist. 2016. PMID: 27317574 Free PMC article. Review.
-
A Novel Use of Olaparib for the Treatment of Metastatic Castration-Recurrent Prostate Cancer.Pharmacotherapy. 2017 Nov;37(11):1406-1414. doi: 10.1002/phar.2027. Pharmacotherapy. 2017. PMID: 28895177 Review.
Cited by
-
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution.Int J Mol Sci. 2024 Apr 7;25(7):4094. doi: 10.3390/ijms25074094. Int J Mol Sci. 2024. PMID: 38612902 Free PMC article. Review.
-
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors.Biomedicines. 2024 Mar 6;12(3):593. doi: 10.3390/biomedicines12030593. Biomedicines. 2024. PMID: 38540206 Free PMC article. Review.
-
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma.Esophagus. 2024 Jul;21(3):328-335. doi: 10.1007/s10388-024-01050-2. Epub 2024 Mar 12. Esophagus. 2024. PMID: 38467986 Free PMC article.
-
Exploiting the DNA Damage Response for Prostate Cancer Therapy.Cancers (Basel). 2023 Dec 23;16(1):83. doi: 10.3390/cancers16010083. Cancers (Basel). 2023. PMID: 38201511 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous